Elmind Capital »

BioCryst Pharmaceuticals shares owned by Elmind Capital

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.5M 1.0M 9.52

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
RA Capital Management
Deerfield Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation

View all funds holding BioCryst Pharmaceuticals